Teva Pharmaceutical Industries Ltd ADR (NYSE:TEVA) - Share price - Overview

Stock Report

Teva Pharmaceutical Industries Ltd TEVA

Last Price
$32.96

Day Change
-0.07|-0.21%

As of 28/03/2017
17:00:26 EDT | USD
Minimum 15 Minutes Delay.

Last Close33.03
Day Range32.79 - 33.20
Mkt Cap33.55Bil
52-Wk Range31.90 - 58.16
Yield %4.11
ISINUS8816242098
Volume4,598,151
P/E470.86
P/S1.45
P/CF6.06

Share Price

Financials
201420152016
More ...
Income Statement
Revenue20,272.0019,652.0021,903.00
Operating Income3,951.003,352.002,154.00
Net Income3,055.001,588.00329.00
Basic EPS3.581.840.07
Avg. Diluted Shares Outstanding858864961
Balance Sheet
Current Assets14,396.0018,398.0016,961.00
Non Current Assets32,024.0035,860.0075,929.00
Total Assets46,420.0054,258.0092,890.00
Current Liabilities12,289.0013,005.0018,519.00
Total Liabilities23,107.0024,489.0059,553.00
Total Equity23,313.0029,769.0033,337.00
Cash Flow
Operating Cash Flow5,127.005,542.005,225.00
Capital Expenditure-929.00-772.00-901.00
Free Cash Flow4,198.004,770.004,324.00

In millions, except "Basic EPS". Currency is USD.

Company Profile

Teva Pharmaceutical Industries Ltd develops, produces and markets generic, branded & OTC medicines. Its products include Copaxone, Azilect and Provigil.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Stock Style

Large-Value

Fiscal Year Ends

December

Employees

56,960
Key Stats
More ...
Price/Earning TTM471.86
Price/Book1.13
Price/Sales TTM1.45
Rev Growth (3 year avg)2.54
EPS Growth (3 year avg)-
Operating Margin % TTM9.83
Net Margin % TTM1.50
ROE TTM0.24
Debt/Equity1.09
Dividends
PreviousLatest
More ...
Declared Date14/11/1613/02/17
Ex-Div01/12/1628/02/17
Paid20/12/1620/03/17
Amnt0.340.34
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.